Kidney Organoid Derived from Human Pluripotent and Adult Stem Cells for Disease Modeling
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kidney disease affects a significant portion of the global population, yet effective therapies are lacking despite advancements in identifying genetic causes. This limitation can be attributed to the absence of adequate in vitro models that accurately mimic human kidney disease, hindering targeted therapeutic development. However, the emergence of human induced pluripotent stem cells (PSCs) and the development of organoids using them have opened up a way to model kidney development and disease in humans, as well as validate the effects of new drugs. To fully leverage their capabilities in these fields, it is crucial for kidney organoids to closely resemble the structure and functionality of adult human kidneys. In this review, we aim to discuss the potential of using human PSCs or adult kidney stem cellderived kidney organoids to model genetic kidney disease and renal cancer.
Abstract
Kidney disease affects a significant portion of the global population, yet effective therapies are lacking despite advancements in identifying genetic causes. This limitation can be attributed to the absence of adequate in vitro models that accurately mimic human kidney disease, hindering targeted therapeutic development. However, the emergence of human induced pluripotent stem cells (PSCs) and the development of organoids using them have opened up a way to model kidney development and disease in humans, as well as validate the effects of new drugs. To fully leverage their capabilities in these fields, it is crucial for kidney organoids to closely resemble the structure and functionality of adult human kidneys. In this review, we aim to discuss the potential of using human PSCs or adult kidney stem cellderived kidney organoids to model genetic kidney disease and renal cancer.
참고문헌 (57)
- Al-Bataineh MM, "Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury", Am J Physiol Renal Physiol, 310, pp.F569~F579 (2016)
- Barker N, "Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro", Cell Stem Cell, 6, pp.25~36 (2010)
- Bingham C, "Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation", Kidney Int, 63, pp.1645~1651 (2003)
- Boj SF, "Organoid models of human and mouse ductal pancreatic cancer", Cell, 160, pp.324~338 (2015)
- Calandrini C, "An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity", Nat Commun, 11, pp.1310~ (2020)
- Capowski EE, "Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines", Development, 146, pp.dev171686~ (2019)
- Chen YW, "A three-dimensional model of human lung development and disease from pluripotent stem cells", Nat Cell Biol, 19, pp.542~549 (2017)
- Clevers H, "Modeling development and disease with organoids", Cell, 165, pp.1586~1597 (2016)
- Coffinier C, "Expression of the vHNF1", HNF1β homeoprotein gene during mouse organogenesis, 1999, pp.89, 211~213
- Coresh J, "Prevalence of chronic kidney disease in the United States", J Am Med Assoc, 298, pp.2038~2047 (2007)
- Creighton CJ, "Comprehensive molecular characterization of clear cell renal cell carcinoma", Nature, 499, pp.43~49 (2013)
- Cruz NM, "Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease", Nat Mater, 16, pp.1112~1119 (2017)
- Davis CF, "The somatic genomic landscape of chromophobe renal cell carcinoma", Cancer Cell, 26, pp.319~330 (2014)
- Decramer S, "Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys", J Am Soc Nephrol, 18, pp.923~933 (2007)
- Doyonnas R, "Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin", J Exp Med, 194, pp.13~28 (2001)
- Dvela-Levitt M, "Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy", Cell, 178, pp.521~535.E23 (2019)
- Eiraku M, "Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals", Cell Stem Cell, 3, pp.519~532 (2008)
- Eneanya ND, "Racial disparities in end-of-life communication and preferences among chronic kidney disease patients", Am J Nephrol, 44, pp.46~53 (2016)
- Fatehullah A, "Organoids as an in vitro model of human development and disease", Nat Cell Biol, 18, pp.246~254 (2016)
- Fitzgerald HC, "Self-renewing endometrial epithelial organoids of the human uterus", Proc Natl Acad Sci USA, 116, pp.23132~23142 (2019)
- Freedman BS, "Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids", Nat Commun, 6, pp.8715~ (2015)
- Gahl WA, "Cystinosis", N Engl J Med, 347, pp.111~121 (2002)
- Gibier JB, "Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase", Biochim Biophys Acta Mol Basis Dis, 1863, pp.1336~1349 (2017)
- Grassi L, "Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases", Cell Death Dis, 10, pp.201~ (2019)
- Gresh L, "A transcriptional network in polycystic kidney disease", EMBO J, 23, pp.1657~1668 (2004)
- Hale LJ, "3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening", Nat Commun, 9, pp.5167~ (2018)
- Harris PC, "Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease", J Clin Invest, 124, pp.2315~2324 (2014)
- Hohwieler M, "Human pluripotent stem cell-derived acinar", ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling, 2017, pp.66, 473~486
- Hollywood JA, "Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine", mTOR inhibition combination therapy for cystinosis, 2020, pp.31, 962~982
- Hsieh JJ, "Renal cell carcinoma", Nat Rev Dis Primers, 3, pp.17009~ (2017)
- Hu H, "Long-term expansion of functional mouse and human hepatocytes as 3D organoids", Cell, 175, pp.1591~1606.E19 (2018)
- Hwang JW, "iPSC-derived embryoid bodies as models of c-Met-mutated hereditary papillary renal cell carcinoma", Int J Mol Sci, 20, pp.4867~ (2019)
- 강희경, "Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome", Experimental and Molecular Medicine, 49, pp.1~6 (2017), 생화학분자생물학회
- Karthaus WR, "Identification of multipotent luminal progenitor cells in human prostate organoid cultures", Cell, 159, pp.163~175 (2014)
- Kim YK, "Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development", Stem Cells, 35, pp.2366~2378 (2017)
- Kirby A, "Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing", Nat Genet, 45, pp.299~303 (2013)
- Kuraoka S, "PKD1-dependent renal cystogenesis in human induced pluripotent stem cell-derived ureteric bud", collecting duct organoids, 2020, pp.31, 2355~2371
- Kurmann AA, "Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells", Cell Stem Cell, 17, pp.527~542 (2015)
- Lasagni L, "Podocyte mitosis: A catastrophe", Curr Mol Med, 13, pp.13~23 (2013)
- Li Z, "Patient-derived renal cell carcinoma organoids for personalized cancer therapy", Clin Transl Med, 12, pp.e970~ (2022)
- Low JH, "Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network", Cell Stem Cell, 25, pp.373~387.E9 (2019)
- Mae SI, "Expansion of human iPSC-derived ureteric bud organoids with repeated branching potential", Cell Rep, 32, pp.107963~ (2020)
- Marston Linehan W, "Comprehensive molecular characterization of papillary renal-cell carcinoma", N Engl J Med, 374, pp.135~145 (2016)
- Nakanishi K, "Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease", J Am Soc Nephrol, 11, pp.760~763 (2000)
- Ogawa M, "Directed differentiation of cholangiocytes from human pluripotent stem cells", Nat Biotechnol, 33, pp.853~861 (2015)
- Przepiorski A, "A simple bioreactor-based method to generate kidney organoids from pluripotent stem cells", Stem Cell Rep, 11, pp.470~484 (2018)
- Sachs N, "A living biobank of breast cancer organoids captures disease heterogeneity", Cell, 172, pp.373~386.E10 (2018)
- Sato T, "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche", Nature, 459, pp.262~265 (2009)
- Schell C, "Glomerular development – shaping the multi-cellular filtration unit", Semin Cell Dev Biol, 36, pp.39~49 (2014)
- Schutgens F, "Tubuloids derived from human adult kidney and urine for personalized disease modeling", Nat Biotechnol, 37, pp.303~313 (2019)
- Sharmin S, "Human induced pluripotent stem cell–derived podocytes mature into vascularized glomeruli upon experimental transplantation", J Am Soc Nephrol, 27, pp.1778~1791 (2016)
- Shimizu T, "A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs", Biochem Biophys Res Commun, 529, pp.1186~1194 (2020)
- Takasato M, "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis", Nature, 536, pp.238~ (2015)
- Tanigawa S, "Organoids from nephrotic disease-derived iPSCs identify impaired NEPHRIN localization and slit diaphragm formation in kidney podocytes", Stem Cell Reports, 11, pp.727~740 (2018)
- Torres VE, "Autosomal dominant polycystic kidney disease", Lancet, 369, pp.1287~1301 (2007)
- Tsai YH, "In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development", Development, 144, pp.1045~1055 (2017)
- Ulinski T, "Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort", J Am Soc Nephrol, 17, pp.497~503 (2006)
